Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction

Serial plasma concentrations of myoglobin, creatine kinase MB (CK-MB) isoenzyme, and cardiac troponin I (cTnI) were measured in 25 patients with a confirmed diagnosis of acute myocardial infarction (AMI), and 74 patients who were suspected of AMI but were subsequently ruled out for this diagnosis. The cutoff concentration for the cTnI assay was optimally determined to be 2.5 ng/mL. Of the three markers, myoglobin had the highest clinical sensitivity (50 percent) when blood was collected between 0 to 6 h after the onset of chest pain. Assays for all serum markers used had high clinical sensitivity (> 93 percent) 6 to 24 h after onset. The CK-MB remained highly sensitive for 48 h, while cTnI was sensitive for up to 72 h. Between 72 and 150 h, cTnI had a clinical sensitivity of 70 percent as compared to 21 percent and 18 percent for myoglobin and CK-MB, respectively. The clinical specificity of cTnI for non-AMI patients was equivalent to CK-MB and significantly higher than for myoglobin. The clinical efficiency of cTnI for all samples was better than either CK-MB or myoglobin, owing mainly to the wider diagnostic window. The specificity of cTnI for 59 patients with chronic renal failure, skeletal muscle trauma and disease was better than all of these markers including cardiac troponin T (cTnT). Results of this study show that cTnI is an effective marker for the retrospective diagnosis of AMI, and consideration should be given to its use in place of CK-MB.

This article has been cited by other articles:

				M. C. Kontos, R. Shah, L. M. Fritz, F. P. Anderson, J. L. Tatum, J. P. Ornato, and R. L. Jesse Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients J. Am. Coll. Cardiol., March 17, 2004; 43(6): 958 - 965. [Abstract] [Full Text] [PDF]

				F. Ghani, A. H.B. Wu, L. Graff, C. Petry, G. Armstrong, F. Prigent, and M. Brown Role of Heart-Type Fatty Acid-binding Protein in Early Detection of Acute Myocardial Infarction Clin. Chem., May 1, 2000; 46(5): 718 - 719. [Full Text] [PDF]

				D. B Sacks Acute coronary ischemia: troponin I and T Vascular Medicine, November 1, 1999; 4(4): 253 - 256. [Abstract] [PDF]

				L. P. Roppolo, R. Fitzgerald, J. Dillow, T. Ziegler, M. Rice, and A. Maisel A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: a pilot study J. Am. Coll. Cardiol., August 1, 1999; 34(2): 448 - 454. [Abstract] [Full Text] [PDF]

				F. S. Apple, R. H. Christenson, R. Valdes Jr., A. J. Andriak, A. Berg, S.-H. Duh, Y.-J. Feng, S. A. Jortani, N. A. Johnson, B. Koplen, et al. Simultaneous Rapid Measurement of Whole Blood Myoglobin, Creatine Kinase MB, and Cardiac Troponin I by the Triage Cardiac Panel for Detection of Myocardial Infarction Clin. Chem., February 1, 1999; 45(2): 199 - 205. [Abstract] [Full Text] [PDF]

				F. S. Apple, A. J. Maturen, R. E. Mullins, P. C. Painter, M. S. Pessin-Minsley, R. A. Webster, J. Spray Flores, R. DeCresce, D. J. Fink, P. M. Buckley, et al. Multicenter Clinical and Analytical Evaluation of the AxSYM Troponin-I Immunoassay to Assist in the Diagnosis of Myocardial Infarction Clin. Chem., February 1, 1999; 45(2): 206 - 212. [Abstract] [Full Text] [PDF]

				R. H. Christenson, F. S. Apple, D. L. Morgan, G. L. Alonsozana, K. Mascotti, M. Olson, R. T. McCormack, F. H. Wians Jr., J. H. Keffer, and S.-H. Duh Cardiac troponin I measurement with the ACCESS® immunoassay system: analytical and clinical performance characteristics Clin. Chem., January 1, 1998; 44(1): 52 - 60. [Abstract] [Full Text] [PDF]

				F. S. Apple, A. Falahati, P. R. Paulsen, E. A. Miller, and S. W. Sharkey Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I Clin. Chem., November 1, 1997; 43(11): 2047 - 2051. [Abstract] [Full Text] [PDF]

				A. H. B. Wu, Y.-J. Feng, J. Nadelman, M. Acampora, and P. N. Fiedler Ectopic Production of Creatine Kinase MB: Updated Evaluation by Mass Assays Clin. Chem., October 1, 1997; 43(10): 2006 - 2007. [Full Text] [PDF]

				M. D. McLaurin, F. S. Apple, E. M. Voss, C. A. Herzog, and S. W. Sharkey Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle Clin. Chem., June 1, 1997; 43(6): 976 - 982. [Abstract] [Full Text] [PDF]

				W. L. Roberts, C. B. Calcote, B. K. De, V. Holmstrom, C. Narlock, F. S. Apple, and D. Whitehair Prevention of Analytical False-Positive Increases of Cardiac Troponin I on the Stratus II Analyzer • A representative of Dade International replies: Clin. Chem., May 1, 1997; 43(5): 860 - 861. [Full Text]

				A. H. B. Wu and J. M. Clive Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain Clin. Chem., February 1, 1997; 43(2): 326 - 332. [Abstract] [Full Text] [PDF]

				A. H. B. Wu, Y.-J. Feng, L. Roper, K. Herbert, and R. Schweizer Cardiac Troponins T and I Before and After Renal Transplantation Clin. Chem., February 1, 1997; 43(2): 411a - 412. [Full Text]